RecallHawk

LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)

SANDOZ

Summary

FDA approved LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) by SANDOZ. ANDA (Generic) approval (Labeling) on 2024-06-18. CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, ORAL.

Details

Source

Drug Approval

External ID

ANDA202588-12

Action Date

2024-06-18

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED), CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, ORAL. Application: ANDA202588

Company

Context & Analysis

SANDOZ has 75 FDA actions in our database.

Frequently Asked Questions

How often does SANDOZ have FDA actions?

SANDOZ has 75 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA202588-12" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions